Galecto, Inc. (GLTO)
24.98
+1.02
(+4.28%)
USD |
NASDAQ |
Jan 16, 16:00
25.00
+0.02
(+0.10%)
After-Hours: 20:00
Galecto EPS Diluted (Quarterly): -2.361 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -0.5884 |
| Ionis Pharmaceuticals, Inc. | -0.805 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| AnaptysBio, Inc. | 0.5208 |
| Ovid Therapeutics, Inc. | -0.171 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.133M |
| Total Expenses (Quarterly) | 3.133M |
| Enterprise Value | 33.58M |
| Earnings Yield | -48.45% |
| Normalized Earnings Yield | -38.90 |